Page 5 - ப்ரைவேட் பத்திரங்கள் வழக்கு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரைவேட் பத்திரங்கள் வழக்கு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரைவேட் பத்திரங்கள் வழக்கு Today - Breaking & Trending Today

Haynes International Inc (HAYN) Q1 2021 Earnings Call Transcript


Operator
Good morning, ladies and gentlemen, and welcome to Haynes International Inc. First Quarter Fiscal 2021 Financial Results Conference Call. [Operator Instructions]
It is now my pleasure to turn the floor over to your host, David Van Bibber. Sir, the floor is yours.
David Van Bibber
Controller and Chief Accounting Officer
Thank you very much for joining us today. With me today are Mike Shor, President and CEO of Haynes International; and Dan Maudlin, Vice President and Chief Financial Officer. Before we get started, I would like to read a brief cautionary note regarding forward-looking statements. This conference call contains statements that are forward-looking within the meaning of the Private Securities Litigation and Reform Act of 1995 and Section 21E of the Securities and Exchange Act of 1934. The words believe, anticipate, plan and similar expressions are intended to identify forward-looking statements. Although we believe our plans, intentions a ....

Mike Shor , Michael Leshock Keybanc , Michaell Shor , Michael Leshock , Stephen Ohara , Chris Olin , David Van Bibber , Exchange Commission , Haynes International Inc , Stephen Michael Ohara Sidoti Company Analyst , Haynes International , Research Analyst , First Quarter Fiscal , Results Conference , David Van , Chief Accounting , Dan Maudlin , Vice President , Chief Financial , Private Securities Litigation , Reform Act , Exchange Act , Chief Executive Officer , Chief Financial Officer , Banc Capital Markets , மைக் ஷோர் ,

Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference


Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference
Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference
CHARLOTTESVILLE, Va., Jan. 11, 2021 Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), today announced that the Company is participating in the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021. Conference specifics are as follows:
Event:
Date: 
The recorded presentation can be accessed by conference participants and the presentation deck can be accessed on the investor relations section of the Diffusion Pharmaceuticals’ website.
About Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most. Diffusion’s lead product candidate, trans sodium croceti ....

United States , Hc Wainwright Bioconnect , Exchange Commission , Diffusion Pharmaceuticals Inc , Diffusion Pharmaceuticals , Diffusion Pharmaceutical , Looking Statements This , Private Securities Litigation , ஒன்றுபட்டது மாநிலங்களில் , பரிமாற்றம் தரகு , பரவல் மருந்துகள் இன்க் , பரவல் மருந்துகள் , பரவல் மருந்து , பார்க்கிறது அறிக்கைகள் இது , ப்ரைவேட் பத்திரங்கள் வழக்கு ,